Trastuzumab is used in the treatment of breast cancer and stomach cancer.
Trastuzumab is a recombinant IgG1 monoclonal antibody that targets the HER2 (human epidermal growth factor receptor) receptors, which are responsible for the over-proliferation of cancer cells in breast and stomach cancers. It destroys cancer cells by inhibiting HER2 and also disrupts various downstream signaling pathways associated with cancer progression.
Common side effects of Trastuzumab include chills, diarrhea, fever, headache, nausea, back pain, vomiting, weakness, and breathlessness.
Trastuzumab 100mg

₹128,434.4
MRP ₹156,627.4
Trastuzumab 100mg

₹155,585

₹128,434.4
MRP ₹156,627.4
Trastuzumab 150mg

₹19,500

₹3,836
MRP ₹5,901.6
Trastuzumab 150mg

₹22,310

₹3,836
MRP ₹5,901.6
Trastuzumab 150mg

₹20,300

₹3,836
MRP ₹5,901.6
Trastuzumab 150mg

₹7,700

₹3,836
MRP ₹5,901.6
Trastuzumab 150mg

₹22,447

₹3,836
MRP ₹5,901.6
Trastuzumab 150mg

₹24,200

₹3,836
MRP ₹5,901.6
Trastuzumab 150mg

₹8,900

₹3,836
MRP ₹5,901.6
Trastuzumab 150mg

₹7,250

₹3,836
MRP ₹5,901.6
Trastuzumab 150mg

₹19,132.7

₹3,836
MRP ₹5,901.6
Trastuzumab 150mg

₹22,447

₹3,836
MRP ₹5,901.6
Trastuzumab 150mg

₹3,836
MRP ₹5,901.6
Trastuzumab 440mg

₹61,132.1

₹14,529.4
MRP ₹17,718.8
Trastuzumab 440mg

₹67,534

₹14,529.4
MRP ₹17,718.8
Trastuzumab 440mg

₹54,662.7

₹14,529.4
MRP ₹17,718.8
Trastuzumab 440mg

₹61,132

₹14,529.4
MRP ₹17,718.8
Trastuzumab 440mg

₹58,820

₹14,529.4
MRP ₹17,718.8
Trastuzumab 440mg

₹40,754

₹14,529.4
MRP ₹17,718.8
Trastuzumab 440mg

₹20,482

₹14,529.4
MRP ₹17,718.8
Trastuzumab 440mg

₹54,662.7

₹14,529.4
MRP ₹17,718.8
Trastuzumab 440mg

₹54,650

₹14,529.4
MRP ₹17,718.8
Trastuzumab 440mg

₹40,425.2

₹14,529.4
MRP ₹17,718.8
Trastuzumab 440mg

₹110,700

₹14,529.4
MRP ₹17,718.8
Trastuzumab 440mg

₹14,529.4
MRP ₹17,718.8
Flat Rs 100 on first app order | Use Code: APP100 |
Flat Rs 100 on first app order
USE CODE: APP100

Download Now